Evidence-based clinical practice guidelines for IgA nephropathy 2014 - Wikidata - wikimedia - TriplyDB

Evidence-based clinical practice guidelines for IgA nephropathy 2014

Evidence-based clinical practice guidelines for IgA nephropathy 2014

http://www.wikidata.org/entity/Q26752264

about

The influence of the Great East Japan earthquake on microscopic polyangiitis: A retrospective observational study.Clinical effects of perazine ferulate tablets combined with eucalyptol limonene pinene enteric soft capsules for treatment of children with IgA nephropathy.Short-term anti-proteinuric effect of tacrolimus is not related to preservation of the glomerular filtration rate in IgA nephropathy: A 5-year follow-up study.Effects of Omega-3 Fatty Acids on Markers of Inflammation in Patients With Chronic Kidney Disease: A Controversial Issue.The clinical relevance of plasma CD147/basigin in biopsy-proven kidney diseases.Acteoside relieves mesangial cell injury by regulating Th22 cell chemotaxis and proliferation in IgA nephropathy.

P2860

Q33674991-ED1C692F-2B1A-4DF2-8ADA-72272604B7D3 Q37002254-19E71373-A141-437D-9542-FC2906775DEC Q47141820-64C8DD98-DE3C-4E5D-BBBF-763E64867CA9 Q47260247-FC3CCE1D-37C2-4A4E-88AB-F701B7CF8E81 Q49874313-71079912-5812-49B0-B142-FAC44F09D530 Q53734191-CDF60498-F70F-4730-9F4B-34CAA25AA4BB

P2860

Evidence-based clinical practice guidelines for IgA nephropathy 2014

http://www.wikidata.org/entity/Q26752264

description

2016 nî lūn-bûn

@nan

2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Evidence-based clinical practice guidelines for IgA nephropathy 2014

@ast

Evidence-based clinical practice guidelines for IgA nephropathy 2014

@en

Evidence-based clinical practice guidelines for IgA nephropathy 2014

@nl

type

label

Evidence-based clinical practice guidelines for IgA nephropathy 2014

@ast

Evidence-based clinical practice guidelines for IgA nephropathy 2014

@en

Evidence-based clinical practice guidelines for IgA nephropathy 2014

@nl

prefLabel

Evidence-based clinical practice guidelines for IgA nephropathy 2014

@ast

Evidence-based clinical practice guidelines for IgA nephropathy 2014

@en

Evidence-based clinical practice guidelines for IgA nephropathy 2014

@nl

P1433

Q26752264-BF73E3F2-F43E-4403-AE12-3883851A14A3

P1476

Q26752264-232D70AA-E83E-43FF-A351-3A458AEC2591

P2093

Q26752264-014D0070-5294-4006-937C-64FC4FED2D23

Q26752264-05CC7439-3567-4769-BA11-5B4980C1D555

Q26752264-1378209B-7F8F-4EEF-8997-05BADB95FC1F

Q26752264-298FD904-74D6-4E48-B856-5BA9B3320871

Q26752264-3F11C4B3-630E-4F92-A750-8E8C182FBC8A

Q26752264-4A79DC30-CB73-48C9-A804-3511E65C38ED

Q26752264-4EDD6657-556C-41E4-9EA0-7171156EC571

Q26752264-5EB41D7C-40BD-4E43-82FC-06DB04035314

Q26752264-7385F7F9-8BC8-40DC-82FA-5E9B7ADEED57

Q26752264-7BEDC2DB-57C7-42E9-94CD-9335CBA87AEA

P2888

Q26752264-EC7C203B-1BAB-458E-A953-F64EE2BB79E2

P304

Q26752264-785B4624-C2EA-4B8D-AB1F-0B6198496739

P31

Q26752264-B08DEB75-1EC2-4329-ADD7-8771272620F8

P3181

Q26752264-A919CEB4-268C-4A16-98FB-5AE25E1B42A8

P356

Q26752264-67D325FA-0E29-4407-A660-86F25926399F

P407

Q26752264-B220A580-E914-4976-9549-FD339FC2A832

P433

Q26752264-F3718E2F-A25A-4770-8F37-802E0F5B6883

P478

Q26752264-A8FA39F7-25E7-4741-BAD6-86DB36DD58E2

P50

Q26752264-6BEE9F65-9B39-49A6-9B58-62372D3B6833

Q26752264-EF68A7AC-91F9-471F-8E7F-FD223E480665

P577

Q26752264-6E74C3C2-D7C5-4AB3-898B-44F99EEFA14B

P6179

Q26752264-7B43D0E5-D6F6-4AAA-B300-3936CEAEAF84

P698

Q26752264-48BCC2D1-A6ED-4691-A00C-66FF115B1519

P932

Q26752264-AC96EADD-E027-487A-BF93-D057F62AB359

P3181

P356

S10157-015-1223-Y

P1433

Clinical and experimental nephrology

P1476

Evidence-based clinical practice guidelines for IgA nephropathy 2014

@en

P2093

Hiroshi Kitamura

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Komatsu

http://www.w3.org/2001/XMLSchema#string

Kazuo Takahashi

http://www.w3.org/2001/XMLSchema#string

Kenjiro Kimura

http://www.w3.org/2001/XMLSchema#string

Maki Urushihara

http://www.w3.org/2001/XMLSchema#string

Makoto Tomita

http://www.w3.org/2001/XMLSchema#string

Masashi Goto

http://www.w3.org/2001/XMLSchema#string

Miki Takahara

http://www.w3.org/2001/XMLSchema#string

Mitsuhiro Sato

http://www.w3.org/2001/XMLSchema#string

Ritsuko Katafuchi

http://www.w3.org/2001/XMLSchema#string

P2888

s10157-015-1223-y

P304

511-535

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1767306

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S10157-015-1223-Y

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Ryohei Yamamoto

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1007215839

http://www.w3.org/2001/XMLSchema#string

P698

27095365

http://www.w3.org/2001/XMLSchema#string

P932

4956709

http://www.w3.org/2001/XMLSchema#string